Clinical Trial Update: Selenium in Mild Thyroid Eye Disease in North America [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating selenium for mild thyroid eye disease in North America has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Associated Ophthalmopathies

Snippet

Sponsor: Columbia University | Conditions: Thyroid Associated Ophthalmopathies | Phase 3 | Status: WITHDRAWN